We should draw up a list of all the questions & topics they failed to address in the Q&A and submit them on mass to IR.
It would make it very hard then for them to not answer our questions fully, given the commitments made in the Q&A about answering questions that weren't properly covered.
Data usage was another topic never covered in the discussion, probably because its fallen off a cliff since they were highlighting it so much in the last quarterly report.
LOTM
- Forums
- ASX - By Stock
- SYT
- Syntonic December Webinar 14/12/2017
Syntonic December Webinar 14/12/2017, page-79
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online